Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $50.93 and last traded at $51.11, with a volume of 145694 shares trading hands. The stock had previously closed at $51.66.
Analysts Set New Price Targets
ACHC has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft increased their target price on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a "hold" rating in a report on Friday, August 2nd. Royal Bank of Canada reiterated an "outperform" rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Friday, September 20th. KeyCorp started coverage on Acadia Healthcare in a report on Friday, October 11th. They set a "sector weight" rating on the stock. Barclays decreased their price objective on Acadia Healthcare from $83.00 to $76.00 and set an "overweight" rating for the company in a research note on Monday, September 30th. Finally, Cantor Fitzgerald restated a "neutral" rating and set a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $86.67.
Check Out Our Latest Report on Acadia Healthcare
Acadia Healthcare Price Performance
The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60. The stock has a fifty day moving average of $69.95 and a 200-day moving average of $69.14. The stock has a market capitalization of $4.71 billion, a price-to-earnings ratio of -362.29, a P/E/G ratio of 1.57 and a beta of 1.29.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The firm had revenue of $796.00 million for the quarter, compared to analyst estimates of $784.38 million. During the same period last year, the business earned $0.92 EPS. Acadia Healthcare's revenue for the quarter was up 8.8% compared to the same quarter last year. On average, equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current fiscal year.
Institutional Trading of Acadia Healthcare
Several institutional investors and hedge funds have recently bought and sold shares of the business. William Blair Investment Management LLC lifted its position in Acadia Healthcare by 20.7% during the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company's stock worth $237,434,000 after acquiring an additional 604,070 shares during the period. Point72 Asset Management L.P. raised its stake in shares of Acadia Healthcare by 266.0% during the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company's stock worth $153,339,000 after purchasing an additional 1,650,040 shares during the last quarter. Bank of New York Mellon Corp grew its position in Acadia Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company's stock valued at $84,382,000 after buying an additional 77,509 shares during the last quarter. Millennium Management LLC increased its stake in Acadia Healthcare by 3,067.8% in the 2nd quarter. Millennium Management LLC now owns 1,090,313 shares of the company's stock valued at $73,640,000 after buying an additional 1,055,894 shares during the period. Finally, Iron Triangle Partners LP raised its position in Acadia Healthcare by 14.0% during the 1st quarter. Iron Triangle Partners LP now owns 902,813 shares of the company's stock worth $71,521,000 after buying an additional 110,820 shares during the last quarter.
Acadia Healthcare Company Profile
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.